Application of HPLC and HPTLC for the simultaneous determination of tizanidine and rofecoxib in pharmaceutical dosage form
Authors:
- S.R. DhaneshwarSDS.R. Dhaneshwar
- Himani AgrawalHAHimani Agrawal
- Abhijit KakadAKAbhijit Kakad
- Bharat PatilBPBharat Patil
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 37 (1) , 27-38
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Stability-indicating HPTLC determination of tizanidine hydrochloride in bulk drug and pharmaceutical formulationsJournal of Pharmaceutical and Biomedical Analysis, 2003
- Validated liquid chromatography method for assay of tizanidine in drug substance and formulated productsAnalytica Chimica Acta, 2003
- Determination of tizanidine in human plasma by gas chromatography–mass spectrometryThe Analyst, 2002
- Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): Rationale for selective inhibition and progress to dateMedicinal Research Reviews, 1996
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- New insights into the mode of action of anti-inflammatory drugsInflammation Research, 1995
- Biological fate of sirdalud in animals and manXenobiotica, 1989
- PHARMACOKINETICS OF ORALLY ADMINISTERED TIZANIDINE IN HEALTHY VOLUNTEERSFundamental & Clinical Pharmacology, 1987
- Tizanidine ? Initial pharmacokinetic studies in patients with spasticityEuropean Journal of Clinical Pharmacology, 1983
- Nuclear magnetic resonance spectroscopy. XIII. Amidines. VII. Proton and carbon-13 nuclear magnetic resonance studies on the tautomerism, geometrical isomerism, and conformation of some cyclic amidines, guanidines, and related systemsJournal of the American Chemical Society, 1975